382 related articles for article (PubMed ID: 11160777)
1. New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers.
Mudaliar S; Henry RR
Annu Rev Med; 2001; 52():239-57. PubMed ID: 11160777
[TBL] [Abstract][Full Text] [Related]
2. Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance: double blind, prospective randomized study.
Stakos DA; Schuster DP; Sparks EA; Wooley CF; Osei K; Boudoulas H
J Cardiol; 2003 Apr; 41(4):183-90. PubMed ID: 12728539
[TBL] [Abstract][Full Text] [Related]
3. The role of troglitazone in treating the insulin resistance syndrome.
Granberry MC; Schneider EF; Fonseca VA
Pharmacotherapy; 1998; 18(5):973-87. PubMed ID: 9758309
[TBL] [Abstract][Full Text] [Related]
4. Are all glitazones the same?
Van Gaal L; Scheen AJ
Diabetes Metab Res Rev; 2002; 18 Suppl 2():S1-4. PubMed ID: 11921431
[TBL] [Abstract][Full Text] [Related]
5. Troglitazone and related compounds: therapeutic potential beyond diabetes.
Fujiwara T; Horikoshi H
Life Sci; 2000 Oct; 67(20):2405-16. PubMed ID: 11065164
[TBL] [Abstract][Full Text] [Related]
6. Troglitazone in type II diabetes mellitus.
Sparano N; Seaton TL
Pharmacotherapy; 1998; 18(3):539-48. PubMed ID: 9620105
[TBL] [Abstract][Full Text] [Related]
7. Pleiotropic effects of thiazolidinediones: implications for the treatment of patients with type 2 diabetes mellitus.
Defronzo RA; Mehta RJ; Schnure JJ
Hosp Pract (1995); 2013 Apr; 41(2):132-47. PubMed ID: 23680744
[TBL] [Abstract][Full Text] [Related]
8. [Against insulin resistance. Insulin sensitizers].
Verspohl EJ; Weiland F
Pharm Unserer Zeit; 2002; 31(3):280-92. PubMed ID: 12071125
[No Abstract] [Full Text] [Related]
9. New therapeutic approaches to reversing insulin resistance.
Sonnenberg GE; Kotchen TA
Curr Opin Nephrol Hypertens; 1998 Sep; 7(5):551-5. PubMed ID: 9818203
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of aleglitazar, a new dual PPAR-α/γ agonist: implications for cardiovascular disease in patients with diabetes mellitus.
Cavender MA; Lincoff AM
Am J Cardiovasc Drugs; 2010; 10(4):209-16. PubMed ID: 20653327
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance and its treatment by thiazolidinediones.
Lebovitz HE; Banerji MA
Recent Prog Horm Res; 2001; 56():265-94. PubMed ID: 11237217
[TBL] [Abstract][Full Text] [Related]
12. Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus.
Parker JC
Adv Drug Deliv Rev; 2002 Nov; 54(9):1173-97. PubMed ID: 12393300
[TBL] [Abstract][Full Text] [Related]
13. [Cardiovascular effects of the thiazolidinedione troglitazone].
Yamada K; Kuzuya H; Nakano T
Nihon Rinsho; 2000 Feb; 58(2):435-9. PubMed ID: 10707572
[TBL] [Abstract][Full Text] [Related]
14. Where thiazolidinediones will fit.
Reasner CA
Diabetes Metab Res Rev; 2002; 18 Suppl 2():S30-5. PubMed ID: 11921436
[TBL] [Abstract][Full Text] [Related]
15. Effects of thiazolidinediones for early treatment of type 2 diabetes mellitus.
Kudzma DJ
Am J Manag Care; 2002 Oct; 8(16 Suppl):S472-82. PubMed ID: 12408410
[TBL] [Abstract][Full Text] [Related]
16. Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus.
Irons BK; Greene RS; Mazzolini TA; Edwards KL; Sleeper RB
Pharmacotherapy; 2006 Feb; 26(2):168-81. PubMed ID: 16466323
[TBL] [Abstract][Full Text] [Related]
17. A review of metabolic and cardiovascular effects of oral antidiabetic agents: beyond glucose-level lowering.
Ginsberg H; Plutzky J; Sobel BE
J Cardiovasc Risk; 1999 Oct; 6(5):337-46. PubMed ID: 10534139
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone: potential beneficial impact on cardiovascular disease.
Viberti GC
Int J Clin Pract; 2003 Mar; 57(2):128-34. PubMed ID: 12661797
[TBL] [Abstract][Full Text] [Related]
19. [Insulin sensitizer. A new therapy option for type 2 diabetic patients].
Filz HP
MMW Fortschr Med; 2000 Sep; 142(38):31-3. PubMed ID: 11050888
[TBL] [Abstract][Full Text] [Related]
20. Rationale for and role of thiazolidinediones in type 2 diabetes mellitus.
Lebovitz HE
Am J Cardiol; 2002 Sep; 90(5A):34G-41G. PubMed ID: 12231077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
